These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 24259657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
    Wells SA, Robinson BG, Gagel RF, Dralle H, Fagin JA, Santoro M, Baudin E, Elisei R, Jarzab B, Vasselli JR, Read J, Langmuir P, Ryan AJ, Schlumberger MJ.
    J Clin Oncol; 2012 Jan 10; 30(2):134-41. PubMed ID: 22025146
    [Abstract] [Full Text] [Related]

  • 10. The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.
    Fallahi P, Ferrari SM, Baldini E, Biricotti M, Ulisse S, Materazzi G, Miccoli P, Antonelli A.
    Expert Rev Anticancer Ther; 2016 Nov 10; 16(11):1109-1118. PubMed ID: 27650489
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vandetanib: in medullary thyroid cancer.
    Frampton JE.
    Drugs; 2012 Jul 09; 72(10):1423-36. PubMed ID: 22715896
    [Abstract] [Full Text] [Related]

  • 13. Vandetanib therapy in medullary thyroid cancer.
    Grabowski P, Briest F, Baum RP, Zaknun JJ, Kulkarni HR, Zeitz M, Hörsch D.
    Drugs Today (Barc); 2012 Nov 09; 48(11):723-33. PubMed ID: 23170308
    [Abstract] [Full Text] [Related]

  • 14. Vandetanib (Caprelsa) for medullary thyroid cancer.
    Med Lett Drugs Ther; 2012 Jan 09; 54(1381):3-4. PubMed ID: 22233588
    [No Abstract] [Full Text] [Related]

  • 15. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.
    Leboulleux S, Bastholt L, Krause T, de la Fouchardiere C, Tennvall J, Awada A, Gómez JM, Bonichon F, Leenhardt L, Soufflet C, Licour M, Schlumberger MJ.
    Lancet Oncol; 2012 Sep 09; 13(9):897-905. PubMed ID: 22898678
    [Abstract] [Full Text] [Related]

  • 16. The safety of vandetanib for the treatment of thyroid cancer.
    Tsang VH, Robinson BG, Learoyd DL.
    Expert Opin Drug Saf; 2016 Aug 09; 15(8):1107-13. PubMed ID: 27301016
    [Abstract] [Full Text] [Related]

  • 17. Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.
    Del Rivero J, Edgerly M, Ward J, Madan RA, Balasubramaniam S, Fojo T, Gramza AW.
    Oncologist; 2019 Jan 09; 24(1):16-e14. PubMed ID: 30297385
    [Abstract] [Full Text] [Related]

  • 18. Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer.
    Koehler VF, Adam P, Frank-Raue K, Raue F, Berg E, Hoster E, Allelein S, Schott M, Kroiss M, Spitzweg C.
    Thyroid; 2021 Mar 09; 31(3):459-469. PubMed ID: 32781914
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy and safety of vandetanib on advanced medullary thyroid carcinoma: single center result from a phase Ⅲ study].
    Wang SX, Zhang XW, Wang XX, An CM, Zhang YB, Liu W, Zhao YF, He XH, Li ZJ, Niu LJ, Tang PZ.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jun 07; 54(6):439-444. PubMed ID: 31262109
    [Abstract] [Full Text] [Related]

  • 20. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
    Wells SA, Gosnell JE, Gagel RF, Moley J, Pfister D, Sosa JA, Skinner M, Krebs A, Vasselli J, Schlumberger M.
    J Clin Oncol; 2010 Feb 10; 28(5):767-72. PubMed ID: 20065189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.